Literature DB >> 33449948

Prognostic importance of numbers of retrieved lymph nodes and positive lymph nodes for ampulla of vater cancer (AVC) in 2347 patients from the Surveillance, Epidemiology, and End Results (SEER) database.

Jiao Feng1, RuiYang Wu2,3, Gang Zhang2, ZhiMing Yang3, Liang Zhang3.   

Abstract

INTRODUCTION: The numbers of retrieved lymph nodes (RLNs) and positive lymph nodes (PLNs) had a significant impact on the survival of patients with ampulla of vater cancer (AVC), but the optimal numbers of the both were controversial.
OBJECTIVE: The cohort study aimed to explore the prognostic value and the optimal point of RLNs and PLNs for AVC.
METHODS: A total of 2347 AVC patients with M0 disease who underwent surgical resection and lymph node dissection from January 2004 to December 2013 were acquired from a prospective database.
RESULTS: The study found that the optimal cut-off values of RLNs were 18 in the N0 cohort and 16 in N1 or entire cohort due to the highest 5-year overall survival (OS) rate and disease-specific survival (DSS) rate and the separation of survival curves (all P < 0.05). In patients with RLNs ≥ 16, patients with PLN = 0 demonstrated significantly better 5-year OS and DSS rates (70.9% and 77.1%) compared to those with PLNs = 1-2 (41.6% and 44.7%; all P < 0.001), and patients with PLNs = 1-2 demonstrated significantly better 5-year OS and DSS rates (41.6% and 44.7%) compared to those with PLNs ≥ 3 (24.3% and 28.0%; all P < 0.001).
CONCLUSIONS: This article recommended that at least 16 lymph nodes will improve the prognosis of AVC patients undergoing surgery. The best cut-off values of PLNs recommended for this study were 0 and 2, which may accurately stratify patients.

Entities:  

Year:  2021        PMID: 33449948      PMCID: PMC7810317          DOI: 10.1371/journal.pone.0244987

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  18 in total

1.  Surgical outcomes and prognostic factors for ampulla of Vater cancer.

Authors:  S B Choi; W B Kim; T J Song; S O Suh; Y C Kim; S Y Choi
Journal:  Scand J Surg       Date:  2011       Impact factor: 2.360

2.  Recurrence patterns after pancreaticoduodenectomy for ampullary cancer.

Authors:  Hongbeom Kim; Wooil Kwon; Jae Ri Kim; Yoonhyeong Byun; Jin-Young Jang; Sun-Whe Kim
Journal:  J Hepatobiliary Pancreat Sci       Date:  2019-04-08       Impact factor: 7.027

3.  Increased number of metastatic lymph nodes in adenocarcinoma of the ampulla of Vater as a prognostic factor: a proposal of new nodal classification.

Authors:  Hyo Jeong Kang; Soo-Heang Eo; Song Cheol Kim; Kwang-Min Park; Young-Joo Lee; Sung Koo Lee; Eunsil Yu; Hyungjun Cho; Seung-Mo Hong
Journal:  Surgery       Date:  2013-11-12       Impact factor: 3.982

4.  Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.

Authors:  Massimo Falconi; Stefano Crippa; Ismael Domínguez; Giuliano Barugola; Paola Capelli; Stefano Marcucci; Stefania Beghelli; Aldo Scarpa; Claudio Bassi; Paolo Pederzoli
Journal:  Ann Surg Oncol       Date:  2008-08-20       Impact factor: 5.344

5.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

6.  Transduodenal Ampullectomy for the Treatment of Early-Stage Ampulla of Vater Cancer.

Authors:  Huisong Lee; Jin Young Park; Wooil Kwon; Jin Seok Heo; Dong Wook Choi; Seong Ho Choi
Journal:  World J Surg       Date:  2016-04       Impact factor: 3.352

7.  Adenocarcinoma of the ampulla of Vater: predictors of survival and recurrence after curative radical resection.

Authors:  Kang Jae Kim; Dong Wook Choi; Woo Seok Kim; Min Jung Kim; Sun Choon Song; Jin Seok Heo; Seong Ho Choi
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-08-31

8.  Biliary Neuroendocrine Neoplasms: Clinical Profiles, Management, and Analysis of Prognostic Factors.

Authors:  Zhibo Zheng; Chuyan Chen; Binglu Li; Hongbo Liu; Liangrui Zhou; Hui Zhang; Chaoji Zheng; Xiaodong He; Wei Liu; Tao Hong; Yupei Zhao
Journal:  Front Oncol       Date:  2019-02-05       Impact factor: 6.244

9.  Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer.

Authors:  Hye Rim Ha; Do-Youn Oh; Tae-Yong Kim; KyoungBun Lee; Kyubo Kim; Kyung-Hun Lee; Sae-Won Han; Eui Kyu Chie; Jin-Young Jang; Seock-Ah Im; Tae-You Kim; Sun-Whe Kim; Yung-Jue Bang
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

10.  Prognostic Value of the Metastatic Lymph Node Ratio in Patients With Resectable Carcinoma of Ampulla of Vater.

Authors:  Chih-Ho Hsu; Tai-Di Chen; Chun-Yi Tsai; Jun-Te Hsu; Chun-Nan Yeh; Yi-Yin Jan; Ta-Sen Yeh; Wen-Chi Chou; Keng-Hao Liu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.